Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors

Touchstone Sands Capital Select Growth Fund Q3 review highlights AI-driven gains and challenges. Explore insights and ...

Touchstone Sands Capital Select Growth Fund Q3 2025 Commentary

Explore Touchstone Sands Capital Select Growth Fund's Q3 2025 performance, AI strategy, and key holdings. Click here to ...
JCN Newswire

Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the ...

Eisai Completes Rolling Submission to US FDA for LEQEMBI (R) IQLIK (TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early ...